Accuray Incorporated (ARAY)

NASDAQ: ARAY · Real-Time Price · USD
2.030
-0.040 (-1.93%)
Dec 11, 2024, 4:00 PM EST - Market closed
-1.93%
Market Cap 204.15M
Revenue (ttm) 444.20M
Net Income (ttm) -16.53M
Shares Out 100.57M
EPS (ttm) -0.17
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 570,092
Open 2.090
Previous Close 2.070
Day's Range 2.010 - 2.100
52-Week Range 1.400 - 3.050
Beta 1.46
Analysts Strong Buy
Price Target 9.00 (+343.35%)
Earnings Date Jan 29, 2025

About ARAY

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, a... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Feb 8, 2007
Employees 987
Stock Exchange NASDAQ
Ticker Symbol ARAY
Full Company Profile

Financial Performance

In 2024, Accuray's revenue was $446.55 million, a decrease of -0.24% compared to the previous year's $447.61 million. Losses were -$15.55 million, 67.5% more than in 2023.

Financial Statements

Analyst Forecast

According to one analyst, the rating for ARAY stock is "Strong Buy" and the 12-month stock price forecast is $9.0.

Price Target
$9.0
(343.35% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

MADISON, Wis. , Nov. 26, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Mike Murphy, the company's new Vice P...

15 days ago - PRNewsWire

Accuray Incorporated (ARAY) Q1 2025 Earnings Call Transcript

Accuray Incorporated (ARAY) Q1 2025 Earnings Call Transcript

5 weeks ago - Seeking Alpha

Accuray Reports Fiscal 2025 First Quarter Financial Results

Strong Start to Fiscal Year, Raises 2025 Guidance MADISON, Wis. , Nov. 6, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended Septembe...

5 weeks ago - PRNewsWire

Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024

MADISON, Wis., Oct. 23, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2025, ended September 30, 2024, during a conference ...

7 weeks ago - PRNewsWire

Accuray Appoints Michael Murphy as VP, Corporate Controller

MADISON, Wis. , Oct. 21, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Michael Murphy, CPA has joined the company as Vice President, Corporate Controller.

7 weeks ago - PRNewsWire

Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence

MADISON, Wis. , Oct. 15, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced that, effective as of today, Suzanne Winter has returned from her temporary medical leave and assumed her fu...

2 months ago - PRNewsWire

Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife® S7™ System Medical Professional Training

Accuray is the first industry partner to open a facility at the Genolier Innovation Hub, created to provide opportunities for clinician-industry collaborations that can help accelerate improvements in...

2 months ago - PRNewsWire

Gifu Prefectural General Medical Center Achieves Milestone with Treatment of the First Cancer Patients in Japan Using the Accuray Radixact® System and VitalHold™ Solution

The Technology Will Play an Important Role in the Hospital's Plan to Expand Patient Access to High Precision Radiation Therapy Treatments MADISON, Wis. , Sept. 10, 2024 /PRNewswire/ -- Accuray Incorpo...

3 months ago - PRNewsWire

Accuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence

MADISON, Wis. , Sept. 3, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that President and Chief Executive Officer Suzanne Winter will be taking a temporary medical leave of ...

3 months ago - PRNewsWire

Accuray Receives CE Mark for a New Helical Radiation Delivery System, Accuray Helix™

Developed for India and other countries where patient access to care with radiotherapy is challenged and where versatility and ease of use are a high priority Drives the next phase of company's strate...

3 months ago - PRNewsWire

Accuray Remains A Perpetual 'Next Year Is Our Year' Story

Accuray posts a strong end to the fiscal year with 16% revenue growth in FQ4, beating expectations and restoring some confidence for the upcoming year. Management's claim that weaker U.S. sales are a ...

4 months ago - Seeking Alpha

Accuray Incorporated (ARAY) Q4 2024 Earnings Call Transcript

Accuray Incorporated (NASDAQ:ARAY) Q4 2024 Earnings Call Transcript August 14, 2024 4:30 PM ET Company Participants Jesse Chew - SVP and Chief Legal Officer Suzanne Winter - President and CEO Ali Per...

4 months ago - Seeking Alpha

Accuray Reports Fourth Quarter and Fiscal 2024 Financial Results

14% Revenue and 8% Orders Growth in Q4; Company issues FY25 Guidance MADISON, Wis. , Aug. 14, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth q...

4 months ago - PRNewsWire

Halifax Health in Florida is First in the U.S. to Treat Patients with Cancer Using the Accuray Radixact® Radiation Delivery System and VitalHold™ Technology

New Technology Provides Advanced Patient Positioning Capabilities With the Radixact System, Making it Easier to Deliver Fast and Effective Radiotherapy Treatments MADISON, Wis. and DAYTONA BEACH, Fla.

4 months ago - PRNewsWire

Accuray to Report Fourth Quarter Fiscal 2024 Financial Results on August 14, 2024

MADISON, Wis. , July 31, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter of fiscal year 2024, ended June 30, 2024, during a conference cal...

4 months ago - PRNewsWire

Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care

The Radixact System will be supplied with ClearRT®, Synchrony®, and the VOLO™ Ultra Optimizer to enhance radiation treatment delivery precision and speed Heidelberg University Hospital is recognized w...

6 months ago - PRNewsWire

Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients

MADISON, Wis. , June 20, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today an agreement with TrueNorth Medical Physics LLC to provide radiation oncology departments with third-p...

6 months ago - PRNewsWire

Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration

MADISON, Wis. , June 12, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the Accuray Precision ® Treatment Planning System (TPS) has been app...

6 months ago - PRNewsWire

Accuray to Participate in the Jefferies Global Healthcare Conference 2024

MADISON, Wis. , May 22, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2024.

7 months ago - PRNewsWire

Accuray Incorporated (ARAY) Q3 2024 Earnings Call Transcript

Accuray Incorporated (NASDAQ:ARAY) Q3 2024 Earnings Conference Call May 1, 2024 4:30 PM ET Company Participants Jesse Chew - SVP and Chief Legal Officer Suzanne Winter - President and CEO Ali Pervaiz...

8 months ago - Seeking Alpha

Accuray Reports Fiscal 2024 Third Quarter Financial Results

MADISON, Wis. , May 1, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter and nine-months ended March 31, 2024.

8 months ago - PRNewsWire

Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024

Celebrates 30 Years of Innovation Through Collaboration and the Development of Technologies That Have Helped Set the Standard of Care for the Industry MADISON, Wis. , April 25, 2024 /PRNewswire/ -- Ac...

8 months ago - PRNewsWire

Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland

The new center is the most recent addition to the company's existing training hubs in Madison, Wisconsin (U.S.), Tokyo, Japan and Tianjin, China  Each facility offers a range of educational opportunit...

8 months ago - PRNewsWire

Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024

MADISON, Wis. , April 17, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2024, ended March 31, 2024, during a conference ca...

8 months ago - PRNewsWire

Accuray Getting Very Little Love Ahead Of A Coming Revenue Ramp

Despite management guidance that points to significant revenue acceleration in the next two quarters, Accuray shares have languished. Market skepticism can be tied in part to the company's track recor...

8 months ago - Seeking Alpha